Exocrine Pancreatic Insufficiency (EPI) is a medical condition that affects the pancreas's ability to produce digestive enzymes, leading to impaired digestion and nutrient absorption. This condition can have a significant impact on a person's quality of life, causing symptoms such as abdominal pain, diarrhea, and malnutrition. However, the field of EPI therapeutics has seen remarkable advancements in recent years, offering hope to those affected by this condition.
